Partner Mark Silver to Speak on Navigating Mass Torts Litigation Strategies in Light of Recent Case Verdicts Webinar

March 12, 2019

Partner Mark Silver will present a live webcast for the Knowledge Group on "Navigating Mass Torts Litigation Strategies in Light of Recent Case Verdicts," Monday, May 20, 2019 from 12:00pm - 2:00pm.

Some of the major topics that will be covered in this course are:

  • Mass Torts Litigation – Overview and Statistics
  • Recent Trends and Developments
  • Notable Cases and Verdicts
  • Top Issues and Challenges
  • Best Litigation Strategies

A large number of mass torts filed over the previous year involve drugs including Xarelto, Risperdal, Opioids and Pradaxa.  One notable case is the mass tort against pharmaceutical giant Hoffmann La-Roche with over 500 lawsuits claiming that users of the company’s acne drug Accutane, developed inflammatory bowel disease. The New Jersey Supreme Court ruled in favor of Hoffmann La-Roche with its dismissal of the mass tort case. The Court said that the plaintiffs failed to prove that Roche failed to provide internal research to the Food and Drug Administration (FDA).

Understanding mass tort case verdicts such as this, as well as the upcoming ones, is critical in devising effective litigation strategies.

To learn more or to register, please click here.